Cogent Biosciences (COGT) – Analyst Comments
-
Jefferies Assumes Cogent (COGT) at Buy, 'A Validated Tool "KIT" for Mast Cell Diseases & GI Cancer'
-
Baird Downgrades Cogent (COGT) to Neutral, 'fairly valued around these levels'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to COGT Stock Lookup